Evotec SE (EVO) Cash & Current Investments (2019 - 2026)
Evotec SE's (EVO) quarterly Cash & Current Investments came in at $520704.3 in Q1 2026, up 26.13% year-on-year from $412815.2 in Q1 2025, and up 667.39% quarter-over-quarter from $67853.9 in Q4 2025.
Evotec SE (EVO) Cash & Current Investments (2019 - 2026) Analysis & Trends
Evotec SE has disclosed Cash & Current Investments across 8 years of filings, most recently posting $520704.3 for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $520704.3, up 26.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $520704.3 (up 26.13% YoY), and the FY2025 annual result was $67853.9, down 99.98% from the prior year.
- Cash & Current Investments came in at $520704.3 for Q1 2026 at Evotec SE, up from $67853.9 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $733.0 million in Q4 2022 to a low of $67853.9 in Q4 2025.
- The 5-year median for Cash & Current Investments is $520704.3 (2026), against an average of $106.5 million.
- Peak annual rise in Cash & Current Investments reached 88.22% in 2022, while the deepest fall reached 100.0% in 2022.
- Evotec SE's Cash & Current Investments stood at $733.0 million in 2022, then decreased by 11.33% to $650.0 million in 2023, then tumbled by 35.35% to $420.2 million in 2024, then sank by 99.98% to $67853.9 in 2025, then surged by 667.39% to $520704.3 in 2026.
- The last three Cash & Current Investments figures came in at $520704.3 (Q1 2026), $67853.9 (Q4 2025), and $283498.2 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 520,704.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 520,704.35 |
| Dec 31, 2025 | 67,853.86 |
| Sep 30, 2025 | 283,498.20 |
| Jun 30, 2025 | 393,923.10 |
| Mar 31, 2025 | 412,815.20 |
| Dec 31, 2024 | 420.21 Mn |
| Sep 30, 2024 | 336,651.50 |
| Jun 30, 2024 | 550,190.48 |
| Mar 31, 2024 | 643,711.72 |
| Dec 31, 2023 | 649.99 Mn |
| Sep 30, 2023 | 451,933.78 |
| Jun 30, 2023 | 452,072.41 |
| Mar 31, 2023 | 445,603.22 |
| Dec 31, 2022 | 733.04 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 949,907.74 |
| Mar 31, 2022 | 959,392.24 |
| Dec 31, 2021 | 981.79 Mn |
| Sep 30, 2021 | 498.34 Bn |
| Jun 30, 2021 | 508,901.02 |